Eligible patients receive individualized treatment recommendations based on their specific goals and clinical profile
Future research is needed to study the use of obesity treatments other than AOM liraglutide and AOM semaglutide, including lifestyle interventions and use of other GLP-1 and non-GLP-1 anti-obesity medications
Close follow-up helps manage dosage, side effect mitigation, and long-term planning
Legal status for research In the United States, BPC-157 is not a controlled substance and may be legally purchased and possessed for laboratory research use
His bald head, goatee, and glasses made him look like a friendlier version of Walter White, from Breaking Bad. Peptides are usually the opening question we get, Koniver told me, in his office